Abstract
Introduction: Genome-wide association studies have identified approximately 1000 lipid-associated loci, but functional variants are less known. Materials & methods: The authors identified RNA modification-related single-nucleotide polymorphisms (RNAm-SNPs) in summary data from a genome-wide association study. By applying Mendelian randomization analysis, the authors identified gene expression levels involved in the regulation of RNAm-SNPs on low-density lipoprotein cholesterol (LDL-C) levels. Results: The authors identified 391 RNAm-SNPs that were significantly associated with LDL-C levels. RNAm-SNPs in NPC1L1, LDLR, APOB, MYLIP, LDLRAP1 and ABCA6 were identified. The RNAm-SNPs were associated with gene expression. The expression levels of 112 genes were associated with LDL-C levels, and some of them (e.g., APOB, SMARCA4 and SH2B3) were associated with coronary artery disease. Conclusion: This study identified many RNAm-SNPs in LDL-C loci and elucidated the relationship among the SNPs, gene expression and LDL-C.
References
- 1. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 370(9602), 1829–1839 (2007).
- 2. . Mechanisms and regulation of cholesterol homeostasis. Nat. Rev. Mol. Cell Biol. 21(4), 225–245 (2020).
- 3. Atherosclerosis. Nat. Rev. Dis. Primers 5(1), 56 (2019).
- 4. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466(7307), 707–713 (2010).
- 5. Discovery and refinement of loci associated with lipid levels. Nat. Genet. 45(11), 1274–1283 (2013).
- 6. The power of genetic diversity in genome-wide association studies of lipids. Nature 600(7890), 675–679 (2021).
- 7. The impact of low-frequency and rare variants on lipid levels. Nat. Genet. 47(6), 589–597 (2015).
- 8. Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am. J. Hum. Genet. 91(5), 823–838 (2012).
- 9. Large-scale genome-wide association studies in East Asians identify new genetic loci influencing metabolic traits. Nat. Genet. 43(10), 990–995 (2011).
- 10. Trans-ethnic fine-mapping of lipid loci identifies population-specific signals and allelic heterogeneity that increases the trait variance explained. PLOS Genet. 9(3), e1003379 (2013).
- 11. Exome chip meta-analysis identifies novel loci and East Asian-specific coding variants that contribute to lipid levels and coronary artery disease. Nat. Genet. 49(12), 1722–1730 (2017).
- 12. Coding-sequence variants are associated with blood lipid levels in 14,473 Chinese. Hum. Mol. Genet. 25(18), 4107–4116 (2016).
- 13. Genome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood inflammatory markers. Nat. Genet. 47(11), 1272–1281 (2015).
- 14. RBP-Var: a database of functional variants involved in regulation mediated by RNA-binding proteins. Nucleic Acids Res. 44(D1), D154–D163 (2016).
- 15. . Determinants of the usage of splice-associated cis-motifs predict the distribution of human pathogenic SNPs. Mol. Biol. Evol. 33(2), 518–529 (2016).
- 16. . Genetic mapping uncovers cis-regulatory landscape of RNA editing. Nat. Commun. 6, 8194 (2015).
- 17. Dynamic methylome of internal mRNA N(7)-methylguanosine and its regulatory role in translation. Cell Res. 29(11), 927–941 (2019).
- 18. . The dynamic epitranscriptome: n6-methyladenosine and gene expression control. Nat. Rev. Mol. Cell Biol. 15(5), 313–326 (2014).
- 19. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature 505(7481), 117–120 (2014).
- 20. N(6)-methyladenosine (m(6)A) recruits and repels proteins to regulate mRNA homeostasis. Nat. Struct. Mol. Biol. 24(10), 870–878 (2017).
- 21. . mRNA traffic control reviewed: n6-methyladenosine (m(6) A) takes the driver's seat. Bio. Essays 40(1), 1700093 (2018).
- 22. m6AVar: a database of functional variants involved in m6A modification. Nucleic Acids Res. 46(D1), D139–D145 (2018).
- 23. . Genome-wide enrichment of m(6)A-associated single-nucleotide polymorphisms in the lipid loci. Pharmacogenomics J. 19(4), 347–357 (2019).
- 24. A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat. Genet. 47(10), 1121–1130 (2015).
- 25. . An atlas of genetic associations in UK Biobank. Nat. Genet. 50(11), 1593–1599 (2018).
- 26. The UK Biobank resource with deep phenotyping and genomic data. Nature 562(7726), 203–209 (2018).
- 27. . Joint analysis of functional genomic data and genome-wide association studies of 18 human traits. Am. J. Hum. Genet. 94(4), 559–573 (2014).
- 28. . HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 40(Database issue), D930–D934 (2012).
- 29. . Genetic effects on gene expression across human tissues. Nature 550(7675), 204–213 (2017).
- 30. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat. Genet. 48(5), 481–487 (2016).
- 31. . Potential link between m(6)A modification and systemic lupus erythematosus. Mol. Immunol. 93, 55–63 (2018).
- 32. . The LDL receptor. Arterioscler. Thromb. Vasc. Biol. 29(4), 431–438 (2009).
- 33. Inactivating mutations in NPC1L1 and protection from coronary heart disease. N. Engl. J. Med. 371(22), 2072–2082 (2014).
- 34. . Pharmacological treatment of a Sardinian patient affected by autosomal recessive hypercholesterolemia (ARH). J. Clin. Lipidol. 9(1), 103–106 (2015).
- 35. . Emerging roles and mechanism of m6A methylation in cardiometabolic diseases. Cells 11(7), 1101 (2022).